Search
Now showing items 81-90 of 99
Recycling and refilling of transmitter quanta at the frog neuromuscular junction
(SABER ULA, 2005-11-18)
Artículo Publicado en: Journal of Physiology (2000), 523.1, pp. 247-258 247
Vesicle size and transmitter release at the frog neuromuscular junction when quantal acetylcholine content is increased or decreased.
(SABER ULA, 2005-07-01)
Vesicle size and transmitter release at the frog
neuromuscular junction when quantal acetylcholine content
is increased or decreased.(Van der Kloot William , Molgó Jordi , Cameron Roger and Colasante Cesare.)
This papers ...
IP³ receptors and Ca²+ signals in adult skeletal muscle satellite cells in situ.
(SABER ULA, 2005-07-01)
IP³ receptors and Ca²+ signals in adult skeletal muscle
satellite cells in situ.(Molgó, Jordi, Colasante, Cesare, Adams, Dany S.
and Jaimovich, Enrique.)
Abstract
In this short article we review muscle satellite cell ...
Neuregulins: Primary or secondary signals for the control of synapse-specific gene expression.
(SABER ULA, 2005-07-01)
Neuregulins: Primary or secondary signals for the
control of synapse-specific gene expression.(Colasante, Cesare.)
Abstract
The selective transcription of acetylcholine receptor (AChR) subunit genes in synaptic myonuclei ...
Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis
(2005)
Cognitive, behavioral, and motor impairments, during progressive
human immunodeficiency virus type 1 (HIV-1)
infection, are linked to activation of brain mononuclear
phagocytes (MP; perivascular macrophages and ...
Experiencia clínica en el uso de inmunosupresores en el transplante renal
(SABER ULA, 2004-06-22)
Glomeruloesclerosis focal y segmentaria asociada con sida
(SABER ULA, 2004-06-22)
Artículo publicado en: Boletín informativo de la Sociedad Venezolana de Nefrología, Vol. II Nº 1, 1999.
Las toxinas urémicas
(SABER ULA, 2003-07-18)
Artículo publicado en: Boletín informativo de la Sociedad Venezolana de Nefrología, Vol. 1 Nº 4, 1998.
Avances en la terapéutica molecular de la depresión
(2003)
Objetivo. Revisar la terapéutica farmacológica antidepresiva
presente y futura basada en los avances de la biotecnología.
Desarrollo. La visión simplista y errónea de un único sistema neurotransmisor
alterado en la depresión ...